CN1468101A - 减少或戒除吸烟的方法 - Google Patents

减少或戒除吸烟的方法 Download PDF

Info

Publication number
CN1468101A
CN1468101A CNA018167357A CN01816735A CN1468101A CN 1468101 A CN1468101 A CN 1468101A CN A018167357 A CNA018167357 A CN A018167357A CN 01816735 A CN01816735 A CN 01816735A CN 1468101 A CN1468101 A CN 1468101A
Authority
CN
China
Prior art keywords
nicotine
time
predetermined period
smoking
dosage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA018167357A
Other languages
English (en)
Chinese (zh)
Inventor
Sl
S·L·博顿
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of CN1468101A publication Critical patent/CN1468101A/zh
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465Nicotine; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34Tobacco-abuse
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Addiction (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CNA018167357A 2000-08-02 2001-08-02 减少或戒除吸烟的方法 Pending CN1468101A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22268500P 2000-08-02 2000-08-02
US60/222,685 2000-08-02

Publications (1)

Publication Number Publication Date
CN1468101A true CN1468101A (zh) 2004-01-14

Family

ID=22833253

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA018167357A Pending CN1468101A (zh) 2000-08-02 2001-08-02 减少或戒除吸烟的方法

Country Status (15)

Country Link
EP (1) EP1313472A4 (fr)
JP (1) JP2004505053A (fr)
KR (1) KR20030022348A (fr)
CN (1) CN1468101A (fr)
AR (1) AR030092A1 (fr)
AU (2) AU2001284704B2 (fr)
BR (1) BR0112837A (fr)
CA (1) CA2418107A1 (fr)
CZ (1) CZ2003306A3 (fr)
EA (1) EA004718B1 (fr)
HU (1) HUP0300680A3 (fr)
MX (1) MXPA03000994A (fr)
PL (1) PL365609A1 (fr)
WO (1) WO2002009709A1 (fr)
ZA (1) ZA200300820B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6660754B1 (en) * 2000-02-15 2003-12-09 Smithkline Beecham Corporation Method for reducing or eliminating smoking
US8042550B2 (en) * 2006-11-02 2011-10-25 Vladimir Nikolaevich Urtsev Smoke-simulating pipe

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5055478A (en) * 1986-06-19 1991-10-08 Cooper Thomas M Method for stopping smoking

Also Published As

Publication number Publication date
AR030092A1 (es) 2003-08-13
WO2002009709A1 (fr) 2002-02-07
BR0112837A (pt) 2003-06-24
WO2002009709A8 (fr) 2003-08-07
PL365609A1 (en) 2005-01-10
AU8470401A (en) 2002-02-13
MXPA03000994A (es) 2004-08-02
ZA200300820B (en) 2004-04-22
EP1313472A4 (fr) 2006-07-26
CA2418107A1 (fr) 2002-02-07
EP1313472A1 (fr) 2003-05-28
AU2001284704B2 (en) 2005-10-13
HUP0300680A2 (hu) 2003-08-28
EA004718B1 (ru) 2004-08-26
JP2004505053A (ja) 2004-02-19
EA200300217A1 (ru) 2003-10-30
CZ2003306A3 (cs) 2003-08-13
HUP0300680A3 (en) 2012-09-28
KR20030022348A (ko) 2003-03-15

Similar Documents

Publication Publication Date Title
Okuyemi et al. Interventions to facilitate smoking cessation
Chaffee et al. Oral and periodontal implications of tobacco and nicotine products
Fowler et al. Intravenous nicotine self-administration and cue-induced reinstatement in mice: effects of nicotine dose, rate of drug infusion and prior instrumental training
Wills et al. Neurobiological mechanisms of nicotine reward and aversion
Benowitz Nicotine addiction
Malcolm et al. The use of nicotine chewing gum as an aid to stopping smoking
Cinciripini et al. An evaluation of a multicomponent treatment program involving scheduled smoking and relapse prevention procedures: Initial findings
Wills et al. Addiction‐related neuroadaptations following chronic nicotine exposure
Di Chiara Behavioural pharmacology and neurobiology of nicotine reward and dependence
US6660754B1 (en) Method for reducing or eliminating smoking
Walsh et al. Treatment of tobacco use and dependence: the role of the dental professional
CN1468101A (zh) 减少或戒除吸烟的方法
Henningfield et al. Pharmacologic determinants of tobacco self-administration by humans
US20140051043A1 (en) Method for behavioral modification
Frederiksen et al. Controlled smoking: Development and maintenance
WO1996027303A1 (fr) Article pour fumeurs exempt de nicotine
Ramseler Session E Smoking Prevention and Cessation.
AU2001284704A1 (en) Method for reducing or eliminating smoking
CA2174747A1 (fr) Utilisation de la lobeline dans le traitement de symptomes de sevrage de nicotine
Bhattacharyya et al. Therapy for Cessation of Smoking
Tromp-Beelen et al. Stopping Smoking
Kalman et al. Tobacco Use Disorder
David Should we recommend nicotine replacement therapy?
Percival et al. Pharmacological management of smoking cessation
Richmond et al. Controlled Trial of the 24-Hour Transdermal Nicotine Patch in Conjunction With Cognitive-Behavioural Therapy: 6-Months’ Results

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication